Groundbreaking research from AHA Scientific Sessions 2015 reveals how bioengineering and new models are transforming cardiovascular science
Imagine holding in your hands a ghost heart—a human heart that has been stripped of its cells, leaving only the intricate protein scaffold that once gave it form. This isn't science fiction; this was the groundbreaking reality presented at the American Heart Association's Scientific Sessions 2015 in Orlando, where more than 18,000 professionals from 100 countries gathered to share the future of cardiovascular science 3 .
Under the tagline "Life Is Why," this premier conference featured more than 5,000 presentations, including 19 late-breaking clinical trials that would shape the course of heart research for years to come 3 . The research presented here didn't just incrementally advance our understanding—it challenged fundamental assumptions about how the heart works, how it fails, and how we might eventually rebuild it.
"Atherosclerosis causes peripheral vascular disease and affects about 8 million people in the USA and 200 million worldwide."
In this article, we'll journey back to these landmark discoveries, from the creation of bioengineered human heart scaffolds to the development of sophisticated animal models that finally let us peer into the complex progression of heart failure. What emerges is a story not just of a pump, but of an organ far more complex, resilient, and remarkable than we ever imagined.
While the conference covered vast territory, several key themes emerged from the basic science presentations that would go on to influence the direction of cardiovascular research:
The creation of acellular human heart matrices that could be repopulated with living cells 4 .
Refined experimental models that more accurately mimic human heart failure 8 .
Research that questioned fundamental assumptions about how the heart functions 5 .
| Research Focus | Key Finding | Potential Impact |
|---|---|---|
| Heart Bioengineering | Successful decellularization of human hearts preserves 3D structure and vascular network | Future possibility of creating functional bioartificial hearts for transplantation |
| Heart Failure Models | Development of more accurate animal models that better replicate human disease | Improved testing of therapeutic interventions before human trials |
| Circulatory Dynamics | Evidence that blood may have inherent biological momentum beyond simple pump mechanics | Potential new approaches to treating circulatory disorders |
Perhaps the most visually stunning basic science presented at the conference came from researchers working on decellularized human heart matrices—a critical step toward the holy grail of cardiovascular medicine: creating a bioartificial human heart 4 .
The research team obtained 39 human hearts and used a detergent called sodium-dodecyl-sulfate (SDS) to carefully remove all cellular material over 4-8 days. This process stripped away everything that would trigger immune rejection while miraculously preserving the heart's intricate three-dimensional architecture and complete vascular network 4 .
39 human hearts obtained for research
SDS detergent applied over 4-8 days to remove cells
3D architecture and vascular network maintained
Laboratory research on tissue engineering and regenerative medicine
The real test came when researchers attempted to recellularize these ghost hearts. They introduced several types of cells to the matrix, including:
| Cell Type | Abbreviation | Origin | Function in Recellularization |
|---|---|---|---|
| Human Cardiac Progenitor Cells | hCPC | Heart tissue | Potential to develop into various cardiac cell types |
| Bone-Marrow Mesenchymal Cells | hMSCs | Bone marrow | Stem cells with regenerative potential |
| Human Endothelial Cells | HUVECs | Umbilical vein | Form lining of blood vessels and heart chambers |
| Cardiomyocytes | H9c1, HL-1 | Heart muscle | Contractile cells that enable heart beating |
The results were remarkable. The endothelial cells naturally migrated to line the blood vessels and heart chambers, recreating a functional endothelial lining. Even more exciting, the mature cardiomyocytes organized themselves into nascent muscle bundles and demonstrated mature calcium dynamics and electrical coupling—essential properties for a beating heart 4 .
| Reagent/Technique | Primary Function | Research Application |
|---|---|---|
| Sodium-dodecyl-sulfate (SDS) | Detergent for cell removal | Creating acellular heart scaffolds |
| Cardiac biomarkers (CK-MB, hsCRP) | Indicators of heart muscle damage | Assessing cardiovascular disease risk |
| Lipoprotein analysis (Apo B, Lp(a)) | Measuring lipid particles | Determining genetic risk factors for CVD |
| Human cardiac progenitor cells | Source of new heart cells | Recellularizing heart scaffolds |
Based on Randox Cardiology Reagents Panel 2
Another significant area of basic science presented at the Sessions involved developing better animal models for heart failure—a crucial step in translating basic discoveries to human treatments. As one research group noted, "The primary goal of experimental animal HF models is to simplify an indeed complex syndrome into manageable research questions in reproducible settings" 8 .
Helped researchers understand how mutations in this giant sarcomeric protein cause inherited forms of dilated cardiomyopathy 8 .
Using daunorubicin to create stable signs of congestive heart failure with lower premature mortality 8 .
This sophisticated model revealed the metabolic stress hearts undergo during chronic volume overload, even when systolic function appears preserved 8 .
Progression of heart failure in the aortic valve regurgitation model
While the bioengineering research captured imaginations, perhaps the most paradigm-challenging presentation came from researchers questioning the fundamental metaphor we've used for centuries: the heart as a simple pump.
This research drew from fascinating embryological observations that blood circulates in spiraling streams before the heart is fully formed, suggesting blood may have its own "biological momentum" that the heart enhances rather than creates 5 . While controversial, this perspective opens new avenues for understanding cardiovascular diseases and developing treatments.
The late-breaking basic science presented at the AHA's Scientific Sessions 2015 offered more than incremental advances—it provided glimpses of a future where we might regenerate damaged hearts, understand cardiovascular function in fundamentally new ways, and model heart disease with unprecedented accuracy.
Potential to rebuild damaged heart tissue
Improved models for drug development
Fundamental shifts in how we view heart function
The ghost hearts—decellularized scaffolds waiting for new life—symbolize both how far we've come and how much remains to be discovered. They represent a future where donor hearts might not be scarce, where heart failure could be treated with engineered tissues, and where our understanding of cardiovascular function transcends simple mechanical metaphors.
The journey from viewing the heart as a simple pump to understanding it as a complex organ that creates energetic vortices, possesses inherent regenerative capacity, and functions as part of an integrated circulatory network continues to inspire researchers.
As these basic science discoveries gradually transform into clinical applications, they carry the potential to revolutionize how we treat our most common cause of death—truly a reason why "Life Is Why."